Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2024-02-01 00:00:00 ET · period of report 2024-01-30 · accession 0001437749-24-002837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-01 | 2024-01-30 | CATX | Williamson Robert F III | Dir | P - Purchase | $0.7131 | +127.2K | 338.8K | +60% | +$90.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-30 | P | A | 42,879 | $0.72 | 335,261 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-30 | P | A | 57,121 | $0.71 | 292,382 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-30 | P | A | 5,127 | $0.71 | 235,261 | D | — | — | |
| 4 | Common | Common Stock | 2024-01-30 | P | A | 18,579 | $0.71 | 230,134 | D | — | — | |
| 5 | Common | Common Stock | 2024-01-30 | P | A | 3,500 | $0.7 | 338,761 | D | — | — |